The DOI matches its Crossref record; 72 of the 72 references it cites were found in a registry or an index.
The concept of psoriasis as a systemic inflammation: implications for disease management
Open accessAbstract
Psoriasis is a systemic, immune‐mediated disorder, characterized by inflammatory skin and joint manifestations. A range of co‐morbidities is associated with psoriasis, including metabolic diseases, such as diabetes, and psychological disorders. Although the systemic nature of psoriasis often remains unrecognized, the inflammatory processes involved may be associated with the development of co‐morbidities, which, themselves, have a significant impact on the patient's health and quality of life. The relative risks of myocardial infarction (MI) and stroke are increased in patients with psoriasis compared with the general population. These are especially seen in younger patients with more severe disease, and are believed to contribute to the 3‐ to 4‐year reduction in life expectancy among patients with severe psoriasis. The recent results of large studies indicate that the increased cardiovascular (CV) risk is at least partially attributable to psoriasis and independent of the presence of metabolic co‐morbidities. The possible interplay between psoriasis and CV disease is complex. Metabolic diseases such as obesity and diabetes have overlapping genetic predispositions with psoriasis. Both conditions are likely to also interact at a functional level because obesity and the up‐regulation of pro‐inflammatory mediators in psoriasis appear to influence adipocyte homoeostasis, inducing non‐professional immune functions. This may perpetuate psoriatic inflammation, displaying similarities to the immunopathogenesis of atherosclerosis. Finally, the disturbed adipokine profile and inflammation associated with psoriasis enhances insulin resistance, causing subsequent endothelial dysfunction, atherosclerosis and eventual coronary events. The differential contribution of psoriasis and uncontrolled classical CV risk factors to the increased CV risk seen in psoriasis patients is not clear. Successful treatment with methotrexate appears to lower the rates of MI in patients with psoriasis. Tumour necrosis factor‐α (TNF‐α) inhibitors are known to counteract insulin resistance and emerging studies demonstrate an even higher protective effect of TNF‐α antagonist therapy against the development of diabetes or CV co‐morbidities in patients. The recent data reviewed here indicate a role for earlier and more appropriate treatment of psoriasis with drugs such as TNF‐α antagonists. Such an approach has the potential to significantly improve patient outcomes through the treatment of psoriasis itself and possibly also in protection against co‐morbidities.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nestle, F. O., Kaplan, D. H., & Barker, J. (2009) · New England Journal of Medicine · doi:10.1056/nejmra0804595 · Cited by 2,786
Pathogenesis and clinical features of psoriasis
Griffiths, C. E., & Barker, J. N. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61128-3 · Cited by 2,158
Risk of myocardial infarction in patients with psoriasis
Gelfand, J. M., Neimann, A. L., Shin, D. B., Wang, X., Margolis, D. J., & Troxel, A. B. (2006) · JAMA · doi:10.1001/jama.296.14.1735 · Cited by 1,899
Interleukin-22, a TH17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis
Zheng, Y., Danilenko, D. M., Valdez, P., Kasman, I., Eastham-Anderson, J., Wu, J., & Ouyang, W. (2007) · Nature · doi:10.1038/nature05505 · Cited by 1,862
Psoriasis Vulgaris Lesions Contain Discrete Populations of Th1 and Th17 T Cells
Lowes, M. A., Kikuchi, T., Fuentes-Duculan, J., Cardinale, I., Zaba, L. C., Haider, A. S., Bowman, E. P., & Krueger, J. G. (2008) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5701213 · Cited by 1,082
Prevalence of cardiovascular risk factors in patients with psoriasis
Neimann, A. L., Shin, D. B., Wang, X., Margolis, D. J., Troxel, A. B., & Gelfand, J. M. (2006) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2006.08.040 · Cited by 1,010
Definition of treatment goals for moderate to severe psoriasis: a European consensus
Mrowietz, U., Kragballe, K., Reich, K., Spuls, P., Griffiths, C. E. M., Nast, A., Franke, J., Antoniou, C., Arenberger, P., Balieva, F., et al. (2011) · Archives of Dermatological Research · doi:10.1007/s00403-010-1080-1 · Cited by 898
Self-citationAdalimumab therapy for moderate to severe psoriasis: A randomized, controlled phase III trial
Menter, A., Tyring, S. K., Gordon, K., Kimball, A. B., Leonardi, C. L., Langley, R. G., Strober, B. E., Kaul, M., Gu, Y., Okun, M., et al. (2008) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2007.09.010 · Cited by 889
Nograles, K. E., Zaba, L. C., Guttman-Yassky, E., Fuentes-Duculan, J., Suárez-Fariñas, M., Cardinale, I., Khatcherian, A., Gonzalez, J., Pierson, K. C., White, T. R., et al. (2008) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2008.08769.x · Cited by 804
Saurat, J. ‐., Stingl, G., Dubertret, L., Papp, K. A., Langley, R. G. B., Ortonne, J. ‐., Unnebrink, K., Kaul, M., Camez, A., & for the CHAMPION Study Investigators (2007) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2007.08315.x · Cited by 798
Davidovici, B. B., Sattar, N., Jörg, P. C., Puig, L., Emery, P., Barker, J. N., van de Kerkhof, P., Ståhle, M., Nestle, F. O., Girolomoni, G., et al. (2010) · Journal of Investigative Dermatology · doi:10.1038/jid.2010.103 · Cited by 711
Pathirana, D., Ormerod, A., Saiag, P., Smith, C., Spuls, P., Nast, A., Barker, J., Bos, J., Burmester, G., Chimenti, S., et al. (2009) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/j.1468-3083.2009.03389.x · Cited by 703
Self-citationDisease concomitance in psoriasis
Henseler, T., & Christophers, E. (1995) · Journal of the American Academy of Dermatology · doi:10.1016/0190-9622(95)91336-x · Cited by 678
Prevalence of metabolic syndrome in patients with psoriasis: a hospital-based case?control study
Gisondi, P., Tessari, G., Conti, A., Piaserico, S., Schianchi, S., Peserico, A., Giannetti, A., & Girolomoni, G. (2007) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2007.07986.x · Cited by 675
Increased prevalence of the metabolic syndrome in patients with moderate to severe psoriasis
Sommer, D. M., Jenisch, S., Suchan, M., Christophers, E., & Weichenthal, M. (2006) · Archives of Dermatological Research · doi:10.1007/s00403-006-0703-z · Cited by 667
Nograles, K. E., Zaba, L. C., Shemer, A., Fuentes-Duculan, J., Cardinale, I., Kikuchi, T., Ramon, M., Bergman, R., Krueger, J. G., & Guttman-Yassky, E. (2009) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2009.03.041 · Cited by 627
Lebwohl, M. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12954-6 · Cited by 548
Jacobsson, L., Turesson, C., Gülfe, A., Kapetanovic, M. C., Petersson, I. F., Saxne, T., & Geborek, P. (2005) · PubMed · Cited by 533
The Risk of Mortality in Patients With Psoriasis: Results From a Population-Based Study
Gelfand, J. M., Troxel, A. B., Lewis, J. D., Kurd, S. K., Shin, D. B., Wang, X., Margolis, D. J., & Strom, B. L. (2007) · Archives of Dermatology · doi:10.1001/archderm.143.12.1493 · Cited by 533
The ‘psoriatic march’: a concept of how severe psoriasis may drive cardiovascular comorbidity
Boehncke, W.-H., Boehncke, S., Tobin, A.-M., & Kirby, B. (2011) · Experimental Dermatology · doi:10.1111/j.1600-0625.2011.01261.x · Cited by 530
Gordon, K. B., Langley, R. G., Leonardi, C., Toth, D., Menter, M. A., Kang, S., Heffernan, M., Miller, B., Hamlin, R., Lim, L., et al. (2006) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2006.05.027 · Cited by 510
Epidemiology and comorbidity of psoriasis in children
Augustin, M., Glaeske, G., Radtke, M. A., Christophers, E., Reich, K., & Schäfer, I. (2010) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2009.09593.x · Cited by 494
Self-citationAbuabara, K., Azfar, R. S., Shin, D. B., Neimann, A. L., Troxel, A. B., & Gelfand, J. M. (2010) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2010.09941.x · Cited by 472
Ahlehoff, O., Gislason, G. H., Charlot, M., Jørgensen, C. H., Lindhardsen, J., Olesen, J. B., Abildstrøm, S. Z., Skov, L., Torp-Pedersen, C., & Hansen, P. R. (2011) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2010.02310.x · Cited by 441
Kimball, A. B., Gladman, D., Gelfand, J. M., Gordon, K., Horn, E. J., Korman, N. J., Korver, G., Krueger, G. G., Strober, B. E., & Lebwohl, M. G. (2008) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2008.01.006 · Cited by 432
Prodanovich, S., Kirsner, R. S., Kravetz, J. D., Ma, F., Martinez, L., & Federman, D. G. (2009) · Archives of Dermatology · doi:10.1001/archdermatol.2009.94 · Cited by 394
Solomon, D. H. (2011) · JAMA · doi:10.1001/jama.2011.878 · Cited by 393
Increased risk for cardiovascular mortality in psoriasis inpatients but not in outpatients
Mallbris, L., Akre, O., Granath, F., Yin, L., Lindelöf, B., Ekbom, A., & Ståhle-Bäckdahl, M. (2004) · European Journal of Epidemiology · doi:10.1023/b:ejep.0000020447.59150.f9 · Cited by 390
PRODANOWICH, S., MA, F., TAYLOR, J., PEZON, C., FASIHI, T., & KIRSNER, R. (2005) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2004.06.017 · Cited by 384
Psoriasis: a possible risk factor for development of coronary artery calcification
Ludwig, R. J., Herzog, C., Rostock, A., Ochsendorf, F. R., Zollner, T. M., Thaci, D., Kaufmann, R., Vogl, T. J., & Boehncke, W.-H. (2007) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2006.07562.x · Cited by 374
Attributable Risk Estimate of Severe Psoriasis on Major Cardiovascular Events
Mehta, N. N., Yu, Y., Pinnelas, R., Krishnamoorthy, P., Shin, D. B., Troxel, A. B., & Gelfand, J. M. (2011) · The American Journal of Medicine · doi:10.1016/j.amjmed.2011.03.028 · Cited by 345
Co-morbidity and Age-related Prevalence of Psoriasis: Analysis of Health Insurance Data in Germany
Augustin, M., Reich, K., Glaeske, G., Schaefer, I., & Radtke, M. (2010) · Acta Dermato Venereologica · doi:10.2340/00015555-0770 · Cited by 337
Self-citationEpidemiology and comorbidities of psoriasis patients in a national database in Taiwan
Tsai, T.-F., Wang, T.-S., Hung, S.-T., Tsai, P. I.-C., Schenkel, B., Zhang, M., & Tang, C.-H. (2011) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2011.03.002 · Cited by 323
Gisondi, P., Del Giglio, M., Di Francesco, V., Zamboni, M., & Girolomoni, G. (2008) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.2008.26427 · Cited by 307
Ryan, C., Leonardi, C. L., Krueger, J. G., Kimball, A. B., Strober, B. E., Gordon, K. B., Langley, R. G., de Lemos, J. A., Daoud, Y., Blankenship, D., et al. (2011) · JAMA · doi:10.1001/jama.2011.1211 · Cited by 289
Psoriasis: is the impairment to a patient’s life cumulative?
Kimball, A., Gieler, U., Linder, D., Sampogna, F., Warren, R., & Augustin, M. (2010) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/j.1468-3083.2010.03705.x · Cited by 282
An Italian Study on Psoriasis and Depression
Esposito, M., Saraceno, R., Giunta, A., Maccarone, M., & Chimenti, S. (2006) · Dermatology · doi:10.1159/000090652 · Cited by 249
Psoriasis patients show signs of insulin resistance
Boehncke, S., Thaci, D., Beschmann, H., Ludwig, R. J., Ackermann, H., Badenhoop, K., & Boehncke, W.-H. (2007) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2007.08190.x · Cited by 248
Psoriasis and risk of atrial fibrillation and ischaemic stroke: a Danish Nationwide Cohort Study
Ahlehoff, O., Gislason, G. H., Jørgensen, C. H., Lindhardsen, J., Charlot, M., Olesen, J. B., Abildstrøm, S. Z., Skov, L., Torp-Pedersen, C., & Hansen, P. R. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehr285 · Cited by 246
Puig, L. (2011) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/j.1468-3083.2011.04065.x · Cited by 224
Späh, F. (2008) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2008.08780.x · Cited by 223
Meijer, K., de Vries, M., Al-Lahham, S., Bruinenberg, M., Weening, D., Dijkstra, M., Kloosterhuis, N., van der Leij, R. J., van der Want, H., Kroesen, B.-J., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017154 · Cited by 207
Effects of etanercept on C-reactive protein levels in psoriasis and psoriatic arthritis
Strober, B., Teller, C., Yamauchi, P., Miller, J. L., Hooper, M., Yang, Y.-C., & Dann, F. (2008) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2008.08628.x · Cited by 200
Brauchli, Y. B., Jick, S. S., Miret, M., & Meier, C. R. (2009) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2008.09020.x · Cited by 187
Wakkee, M., Herings, R. M. C., & Nijsten, T. (2010) · Journal of Investigative Dermatology · doi:10.1038/jid.2009.321 · Cited by 173
Interleukin-12, interleukin-23, and psoriasis: Current prospects
Torti, D. C., & Feldman, S. R. (2007) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2007.07.016 · Cited by 143
Managing comorbid disease in patients with psoriasis
Boehncke, W., Boehncke, S., & Schön, M. P. (2010) · BMJ · doi:10.1136/bmj.b5666 · Cited by 139
Reich, K., Langley, R. G. B., Lebwohl, M., Szapary, P. O., Guzzo, C. A., Yeilding, N. M., Li, S., Hsu, M.-C., & Griffiths, C. E. M. (2011) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2011.10257.x · Cited by 137
Self-citationKimball, A. B., Szapary, P. O., Mrowietz, U., Reich, K., Langley, R. G. B., You, Y., Hsu, M.-C., Yeilding, N. M., Rader, D. J., & Mehta, N. N. (2011) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2011.06.035 · Cited by 136
Self-citationInfliximab Restores Glucose Homeostasis in an Animal Model of Diet-Induced Obesity and Diabetes
ARAUJO, E. P. D., de Souza, C. T., Ueno, M., Cintra, D. E., Bértolo, M. B., Carvalheira, J. B. C., Saad, M. J. A., & Velloso, L. A. (2007) · Endocrinology · doi:10.1210/en.2007-0132 · Cited by 129
Boehncke, S., Salgo, R., Garbaravičienė, J., Beschmann, H. A., Hardt, K., Diehl, S., Fichtlscherer, S., Thaçi, D., & Boehncke, W. (2011) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/j.1468-3083.2010.03947.x · Cited by 120
Coronary Heart Disease and Stroke Risk in Patients with Psoriasis: Retrospective Analysis
Kimball, A. B., Guérin, A., Latrémouille-Viau, D., Yu, A. P., Gupta, S. R., Bao, Y., & Mulani, P. M. (2010) · The American Journal of Medicine · doi:10.1016/j.amjmed.2009.08.022 · Cited by 115
Bis, J. C., Heckbert, S. R., Smith, N. L., Reiner, A. P., Rice, K. M., Lumley, T., Hindorff, L. A., Marciante, K. D., Enquobahrie, D. A., Monks, S. A., et al. (2007) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2007.09.031 · Cited by 91
Stern, R. S., & Huibregtse, A. (2011) · Journal of Investigative Dermatology · doi:10.1038/jid.2010.399 · Cited by 89
Psoriasis: comorbidities and associations.
Farley, E., & Menter, A. (2011) · PubMed · Cited by 87
Danik, J. S., Paré, G., Chasman, D. I., Zee, R. Y. L., Kwiatkowski, D. J., Parker, A. N., Miletich, J. P., & Ridker, P. M. (2009) · Circulation Cardiovascular Genetics · doi:10.1161/circgenetics.108.825273 · Cited by 86
Li, Y., & Begovich, A. B. (2009) · Seminars in Immunology · doi:10.1016/j.smim.2009.04.002 · Cited by 83
Chen, Y., Shen, J., Wu, C., Chang, Y.-T., Chen, C., & Lee, F.-Y. (2008) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2008.09.046 · Cited by 78
Garbaravičienė, J., Diehl, S., Varwig, D., Bylaitė, M., Ackermann, H., Ludwig, R. J., & Boehncke, W. (2010) · Experimental Dermatology · doi:10.1111/j.1600-0625.2010.01095.x · Cited by 72
Kimball, A. B., Bensimon, A. G., Guérin, A., Yu, A. P., Wu, E. Q., Okun, M. M., Bao, Y., Gupta, S. R., & Mulani, P. M. (2010) · American Journal of Clinical Dermatology · doi:10.2165/11530640-000000000-00000 · Cited by 64
Psoriasis and Cardiovascular Risk: Strength in Numbers
Gelfand, J. M., Azfar, R. S., & Mehta, N. N. (2010) · Journal of Investigative Dermatology · doi:10.1038/jid.2010.12 · Cited by 62
Psoriasis Is Not a Useful Independent Risk Factor for Cardiovascular Disease
Stern, R. S. (2010) · Journal of Investigative Dermatology · doi:10.1038/jid.2009.446 · Cited by 60
Phillips, C. M., Goumidi, L., Bertrais, S., Ferguson, J. F., Field, M. R., Kelly, E. D., Mehegan, J., Peloso, G. M., Cupples, L. A., Shen, J., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1081 · Cited by 60
Enquobahrie, D. A., Smith, N. L., Bis, J. C., Carty, C. L., Rice, K. M., Lumley, T., Hindorff, L. A., Lemaître, R. N., Williams, M. A., Siscovick, D. S., et al. (2008) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2008.02.052 · Cited by 58
Determinants of social anxiety and social avoidance in psoriasis outpatients
Schneider, G., Heuft, G., & Hockmann, J. (2011) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/j.1468-3083.2011.04307.x · Cited by 55
Morange, P., Trégouët, D., Godefroy, T., Saut, N., Bickel, C., Rupprecht, H. J., Lackner, K. J., Barbaux, S., Poirier, O., Peiretti, F., et al. (2008) · Journal of Molecular Medicine · doi:10.1007/s00109-008-0375-6 · Cited by 52
Pereira, M. G., Brito, L., & Smith, T. (2011) · International Journal of Behavioral Medicine · doi:10.1007/s12529-011-9174-5 · Cited by 40
Warnecke, C., Manousaridis, I., Herr, R. M., Terris, D. D., Goebeler, M., Goerdt, S., & Peitsch, W. K. (2011) · European Journal of Dermatology · doi:10.1684/ejd.2011.1467 · Cited by 38
Vašků, V., Kaňková, K., Vašků, A., Mužı́k, J., Hollá, L. I., Semrádová, V., & Vácha, J. (2002) · Archives of Dermatological Research · doi:10.1007/s00403-002-0301-7 · Cited by 27
Sánchez, F. O. N., Reddy, M., Sakuraba, K., Ståhle, M., & Alarcón-Riquelme, M. E. (2008) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5701254 · Cited by 17
González-Enríquez, G. V., Rubio-Benítez, M. I., Garcia-Gallegos, V. M., Buen, E. P., Troyo‐Sanromán, R., & Leal-Cortés, C. Á. (2008) · Archives of Medical Research · doi:10.1016/j.arcmed.2008.07.007 · Cited by 11
Can Treatment of Chronic Inflammatory Diseases Reduce the Risk of Diabetes Mellitus?
Bongartz, T. (2011) · JAMA · doi:10.1001/jama.2011.884 · Cited by 9
Cited by
Boehncke, W.-H., & Schön, M. P. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61909-7 · Cited by 2,542
Management of psoriasis as a systemic disease: what is the evidence?
Korman, N. J. (2020) · British Journal of Dermatology · doi:10.1111/bjd.18245 · Cited by 539
Paul, C., Cather, J., Gooderham, M., Poulin, Y., Mrowietz, U., Ferrandiz, C., Crowley, J., Hu, C., Stevens, R. M., Shah, K., et al. (2015) · British Journal of Dermatology · doi:10.1111/bjd.14164 · Cited by 484
Samarasekera, E. J., Neilson, J. M., Warren, R. B., Parnham, J., & Smith, C. H. (2013) · Journal of Investigative Dermatology · doi:10.1038/jid.2013.149 · Cited by 298
Vitamin D and its role in psoriasis: An overview of the dermatologist and nutritionist
Barrea, L., Savanelli, M. C., Di Somma, C., Napolitano, M., Megna, M., Colao, A., & Savastano, S. (2017) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-017-9411-6 · Cited by 257
Metadata
- Authors
- Reich, K.
- Venue
- Journal of the European Academy of Dermatology and Venereology
- Publisher
- Wiley
- Published
- 2012-02-22
- Volume
- 26
- Issue
- s2
- Pages
- 3-11
- ISSN
- 0926-9959 (ISSN-L)
- 1468-3083
- OpenAlex
- W1543621601
- Cited by
- 360
- References
- 72
- FWCI
- 11.83
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.